Education
About Us
Working with TipRanks
Follow Us
Ian Nicholson Insider Profile
4 Followers
Ian Nicholson, Director at Bioventix, holds 13.50K shares in Bioventix (Ticker: GB:BVXP), holds 13.00K shares in Clinigen (Ticker: GB:CLIN), holds 2.36K shares in Consort Medical (Ticker: GB:CSRT). Most recently, Ian Nicholson Bought ― shares of Bioventix on Oct 30, 2025 for an estimated value of 9.32K.
Profitable Transactions
2 out of 8 Profitable Transactions
Average Return
-29.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Ian Nicholson holds in companies
Most Profitable Insider Trade
Stock:
Consort Medical
(CSRT)
(CSRT)
Rating:Informative Buy
Date:Dec 09, 2014 - Dec 09, 2015
Return:+24.10%
The most profitable trade made by Ian Nicholson
Ian Nicholson's Trading History
Bioventix
Oct 30, 2025
Director
Informative Buy
9.32K
£276.75K
Consort Medical
Aug 12, 2019
―
Informative Buy
9.94K
£27.16K
Clinigen
Oct 28, 2020
―
Informative Buy
18.08K
£120.25K
List of latest transactions for each holding click on a transaction to see Ian Nicholson's performance on stock
You May Also Like
Ian Nicholson insider profile FAQ
What is the percentage of profitable transactions made by Ian Nicholson?
The percentage of profitable transactions made by Ian Nicholson is 25%.
What is the average return per transaction made by Ian Nicholson?
The average return per transaction made by Ian Nicholson is -29.10%.
What stocks does Ian Nicholson hold?
Ian Nicholson holds: GB:BVXP, GB:CSRT, GB:CLIN stocks.
What was Ian Nicholson’s latest transaction?
Ian Nicholson latest transaction was an Informative Buy of 9.32K.
What was Ian Nicholson's most profitable transaction?
Ian Nicholson’s most profitable transaction was an Informative Buy of GB:CSRT stock on December 9, 2014. The return on the trade was 24.10%.
What is Ian Nicholson's role in Bioventix?
Ian Nicholson's role in Bioventix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.